Stocks-BCRX-BioCryst Pharmaceuticals Inc

BCRX BioCryst Pharmaceuticals Inc

10.56 -0.08 (-0.71%)
Delayed Prices By NASDAQ, in USD Market Open
Invest
Invest

Overview

Prev Close10.64
Day's Range 10.38 - 10.67
52 Week Range 7.62 - 19.95
Average Volume (3M)2.65M
1-Year Return-35.49%
Beta1.379
Market Cap1.98B
P/E Ratio
Revenue238.44M
EPS-1.0445
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Biotechnology
CEO Jon P. Stonehouse
Employees 358

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: BioCryst Pharmaceuticals Inc's revenues increased by 782.38% and amounted to 157.17M. Net income decreased by 0.68% to -184.06M. Net assets decreased by NaN to N/A and EPS decreased from -1.09 to N/A.
BCRX's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
97.60%
Net Profit Margin
-464.18%
Operating Margin
-64.71%
Return On Investment
-118.86%
12/21
03/22
06/22
09/22
Total Revenue
47.16M
49.92M
65.53M
75.83M
Gross Profit
46.74M
49.69M
65.29M
72.21M
Operating Income
-52.18M
-49.96M
-34.72M
-17.45M
Net Income
-17.78M
-74.2M
-58.86M
-42.52M